Complete Filing Data
VEEA INC. reported Net Income Loss of -$47.55 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean VEEA INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Net Income Loss | -$47.5M | -$15.6M | $10.6M | $6.6M |
| Operating Income Loss | -$84.1M | -$10.4M | -$4.1M | -$2.9M |
| Nonoperating Income Expense | $36.5M | -$5.3M | $14.7M | $9.5M |
| Interest Expense Debt | $759.8K | |||
| Selling And Marketing Expense | $811.5K | $215.3K | ||
| Revenues | $141.8K | $9.1M | ||
| Operating Expenses | $84.1M | $19.0M | ||
| Gross Profit | $58.5K | $8.6M | ||
| General And Administrative Expense | $26.6M | $17.2M | ||
| Cost Of Goods And Services Sold | $83.3K | $466.8K | ||
| Research And Development Expense | $1.4M | $693.4K | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $795.7K | -$1.4M | ||
| Other Nonoperating Income | $21.4K | $60.0K | ||
| Other Nonoperating Expense | $244.7K | $21.9K | ||
| Interest Expense Nonoperating | $1.8M | $5.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | $1.4M | -$7.4M | $4.3M | -$33.3M | -$7.3M | -$6.5M | $2.0M | -$7.1M | -$4.3M | $2.5M | $1.9M | $3.4M | $2.8M | $2.1M | $342.6K |
| Operating Income Loss | -$4.7M | -$4.9M | -$5.8M | -$57.5M | -$6.8M | -$6.1M | $3.4M | -$579.0K | -$1.2M | -$633.1K | -$1.5M | -$509.1K | -$481.9K | -$822.9K | -$89.6K |
| Nonoperating Income Expense | $6.0M | -$2.5M | $10.1M | $24.2M | -$440.6K | -$457.0K | -$1.4M | $3.1M | $733.2K | $3.1M | $3.4M | $3.9M | $3.3M | $2.9M | $432.1K |
| Interest Expense Debt | $234.5K | $417.3K | $279.0K | $106.4K | $28.5K | $0.00 | $0.00 | ||||||||
| Selling And Marketing Expense | $15.6K | $40.5K | $349.3K | $80.9K | $292.1K | $86.3K | $137.9K | ||||||||
| Revenues | $144.9K | $72.9K | $14.3K | $50.7K | $40.8K | $16.8K | $9.0M | ||||||||
| Operating Expenses | $4.8M | $5.0M | $5.8M | $57.5M | $6.8M | $6.1M | $5.6M | ||||||||
| Gross Profit | $91.9K | $68.3K | $1.9K | $35.7K | $10.1K | $4.8K | $9.0M | ||||||||
| General And Administrative Expense | $4.5M | $4.8M | $5.1M | $2.0M | $5.8M | $5.8M | $5.2M | ||||||||
| Cost Of Goods And Services Sold | $53.0K | $4.6K | $12.3K | $15.0K | $30.7K | $12.0K | $24.3K | ||||||||
| Research And Development Expense | $53.4K | $215.6K | $356.8K | $701.9K | $94.2K | $185.8K | |||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $35.1K | -$1.6M | $122.7K | $365.4K | $894.2K | -$1.3M | $251.5K | ||||||||
| Other Nonoperating Income | $879.00 | $461.00 | $772.00 | $8.7K | $10.1K | $2.6K | |||||||||
| Other Nonoperating Expense | $19.2K | $12.6K | $36.00 | $6.5K | |||||||||||
| Interest Expense Nonoperating | $442.9K | $433.1K | $946.5K | $451.9K | $444.2K | $456.8K | $1.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Stockholders Equity * | -$11.5M | -$30.3M | -$21.2M | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $185.9K | $107.2K | $0.00 | ||
| Retained Earnings Accumulated Deficit | -$170.3M | -$15.3M | -$21.2M | ||
| Liabilities Current | $32.2M | $3.9M | $1.2M | ||
| Liabilities And Stockholders Equity | $20.8M | $324.0M | $319.7M | ||
| Liabilities | $32.3M | $15.4M | $21.7M | ||
| Assets Current | $14.0M | $130.0K | $450.9K | ||
| Assets | $20.8M | $324.0M | $319.7M | ||
| Goodwill | $4.6M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$4.3M | $5.8M | -$20.8K | $107.2K | |
| Cash And Cash Equivalents At Carrying Value | $1.7M | $6.0M | $86.4K | ||
| Temporary Equity Accretion To Redemption Value Adjustment | -$4.7M | ||||
| Operating Lease Right Of Use Asset Amortization Expense | $428.0K | $793.2K | |||
| Assets Held In Trust Noncurrent | $323.9M | $319.2M | |||
| Accrued Liabilities Current | $4.7M | ||||
| Temporary Equity Accretion To Redemption Value | $5.9M | $4.7M | $27.1M | ||
| Other Liabilities Current | $259.0K | ||||
| Intangible Assets Net Excluding Goodwill | $628.5K | ||||
| Reduction Of Deferred Underwriter Fee Payable | $328.5K | ||||
| Property Plant And Equipment Net | $376.7K | ||||
| Prepaid Expense And Other Assets Current | $513.7K | ||||
| Investments | $451.9K | ||||
| Inventory Net | $7.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$4.3M | -$10.9M | -$11.7M | -$17.0M | -$8.0M | -$11.7M | -$5.0M | -$11.5M | -$26.5M | -$29.7M | -$21.5M | -$30.3M | -$15.4M | -$16.4M | -$17.8M | -$21.7M | -$24.5M | -$25.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.1M | $238.0K | $247.3K | $1.7M | $2.8M | $869.6K | $5.6M | $6.0M | $1.2M | $20.9K | $97.8K | $108.9K | $73.7K | $267.7K | $368.2K | |||||
| Retained Earnings Accumulated Deficit | -$219.6M | -$220.9M | -$213.5M | -$217.8M | -$216.9M | -$16.3M | -$19.5M | -$15.4M | -$16.4M | -$17.8M | -$21.7M | $2.4M | $342.6K | |||||||
| Liabilities Current | $28.4M | $31.6M | $25.4M | $20.1M | $21.0M | $8.4M | $9.0M | $3.6M | $3.0M | $1.7M | $177.3K | $150.1K | $1.0M | |||||||
| Liabilities And Stockholders Equity | $29.5M | $28.6M | $20.0M | $21.1M | $45.0M | $36.7M | $36.2M | $321.4M | $320.0M | $319.8M | $320.3M | $320.7M | $303.2M | |||||||
| Liabilities | $33.7M | $39.5M | $31.7M | $38.1M | $53.0M | $9.5M | $13.9M | $15.6M | $16.7M | $18.4M | $22.7M | $26.0M | $28.2M | |||||||
| Assets Current | $16.3M | $15.2M | $13.7M | $14.9M | $38.2M | $285.0K | $135.2K | $231.3K | $275.6K | $555.6K | $914.2K | $949.3K | $3.2M | |||||||
| Assets | $29.5M | $28.6M | $20.0M | $21.1M | $45.0M | $36.7M | $36.2M | $321.4M | $320.0M | $319.8M | $320.3M | $320.7M | $303.2M | |||||||
| Goodwill | $5.2M | $5.2M | $4.9M | $4.8M | $5.1M | $4.8M | $4.8M | $4.8M | $4.6M | $4.8M | $4.6M | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.4M | -$361.3K | $11.4K | $160.5K | ||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $32.8K | $73.7K | $267.7K | $107.2K | $368.2K | $704.0K | $2.3M | $0.00 | ||||||||||||
| Temporary Equity Accretion To Redemption Value Adjustment | $484.1K | $550.9K | -$1.1M | -$786.3K | -$3.6M | $495.7K | ||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $88.0K | $166.5K | ||||||||||||||||||
| Assets Held In Trust Noncurrent | $36.4M | $36.1M | $35.6M | $35.1M | $55.2M | $54.4M | $321.2M | $319.7M | $319.3M | $319.2M | $319.2M | $300.0M | ||||||||
| Accrued Liabilities Current | $1.2M | $1.9M | $1.0M | $1.9M | $6.2M | $100.1K | $103.0K | $993.4K | ||||||||||||
| Temporary Equity Accretion To Redemption Value | $1.1M | $786.3K | $3.6M | $1.4M | $495.7K | $0.00 | $19.2M | $300.0M | ||||||||||||
| Other Liabilities Current | $30.5K | $121.6K | $235.0K | |||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $7.6M | $7.7M | $898.1K | $786.1K | $757.7K | $628.5K | ||||||||||||||
| Reduction Of Deferred Underwriter Fee Payable | $0.00 | $328.5K | $0.00 | $0.00 | ||||||||||||||||
| Property Plant And Equipment Net | $113.5K | $137.2K | $171.4K | $210.6K | $252.2K | |||||||||||||||
| Prepaid Expense And Other Assets Current | $5.5M | $5.5M | $5.6M | $5.6M | $5.6M | |||||||||||||||
| Investments | $236.5K | $235.7K | $235.7K | $235.6K | $452.6K | |||||||||||||||
| Inventory Net | $9.6M | $9.4M | $7.8M | $7.5M | $8.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$25.6M | -$12.7M | -$1.0M | -$2.1M |
| Net Cash Provided By Used In Financing Activities | $21.6M | $18.6M | $1.0M | $321.5M |
| Net Cash Provided By Used In Investing Activities | -$265.4K | -$155.1K | $0.00 | -$319.2M |
| Proceeds From Related Party Debt | $5.3M | $2.2M | $1.0M | $0.00 |
| Increase Decrease In Accrued Liabilities | $1.2M | $340.5K | $1.6M | $1.1M |
| Proceeds From Issuance Of Common Stock | $10.0M | $17.3M | $0.00 | $312.8M |
| Increase Decrease In Prepaid Expense | $7.2K | -$348.8K | $392.4K | |
| Share Based Compensation | $6.7M | $484.6K | ||
| Payments To Acquire Intangible Assets | $219.2K | $120.1K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $5.1M | $388.7K | ||
| Increase Decrease In Operating Lease Liability | -$193.7K | -$844.2K | ||
| Increase Decrease In Inventories | $639.3K | $148.0K | ||
| Increase Decrease In Accounts Payable | $341.9K | -$1.6M | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$36.7K | $58.2K | ||
| Increase Decrease In Due To Related Parties | $96.3K | $120.0K | $115.0K | |
| Payments To Acquire Property Plant And Equipment | $46.2K | $35.0K | ||
| Proceeds From Stock Options Exercised | $79.5K | $4.00 | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.9M | $1.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$3.7M | -$10.7M | -$238.6K | -$339.5K | $30.6K |
| Net Cash Provided By Used In Financing Activities | $2.4M | $10.4M | -$272.4M | $500.0K | $302.2M |
| Net Cash Provided By Used In Investing Activities | -$132.0K | -$74.1K | $272.6M | $0.00 | -$300.0M |
| Proceeds From Related Party Debt | $485.0K | $250.0K | $500.0K | $0.00 | |
| Increase Decrease In Accrued Liabilities | -$829.4K | -$98.6K | $944.0K | $35.0K | $993.4K |
| Proceeds From Issuance Of Common Stock | $604.4K | $475.0K | $480.0K | $0.00 | $293.2M |
| Increase Decrease In Prepaid Expense | $51.5K | $59.3K | -$104.5K | $898.3K | |
| Share Based Compensation | $50.0K | $62.7K | |||
| Payments To Acquire Intangible Assets | $132.0K | $44.5K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$100.5K | $4.9M | |||
| Increase Decrease In Operating Lease Liability | -$91.1K | -$146.5K | |||
| Increase Decrease In Inventories | $318.5K | $63.0K | |||
| Increase Decrease In Accounts Payable | $2.2M | $58.9K | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.0K | -$19.7K | |||
| Increase Decrease In Due To Related Parties | $30.0K | $30.0K | $30.0K | $25.0K | |
| Payments To Acquire Property Plant And Equipment | $29.5K | ||||
| Proceeds From Stock Options Exercised | $11.00 | ||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $538.7K | $944.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Diluted EPS * | -$1.88 | -$0.97 | ||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 25.3M | 16.2M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 25.3M | 16.2M | ||
| Earnings Per Share Basic | $-1.88 | $-0.97 | ||
| Common Stock Shares Authorized | 551.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | |||
| Common Stock Shares Issued | 19.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.03 | -$0.19 | $0.12 | -$1.49 | -$0.34 | -$0.31 | $0.12 | $0.17 | $0.04 | |||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 5.0M | 5.0M | 5.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 45.6M | 38.8M | 36.4M | 22.3M | 21.3M | 21.1M | 16.4M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 45.7M | 38.8M | 36.6M | 22.3M | 21.3M | 21.1M | 16.4M | |||||||
| Earnings Per Share Basic | $0.03 | $-0.19 | $0.12 | $-1.49 | $-0.34 | $-0.31 | $0.12 | |||||||
| Common Stock Shares Authorized | 551.0M | 551.0M | 500.0M | 551.0M | 500.0M | |||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Common Stock Shares Issued | 50.2M | 40.9M | 36.5M | 36.2M | 35.7M | 2.7M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$200.1K | $1.3M | -$9.0M | -$9.2M |
| Investment Income Interest | $1.9K | $4.7M | $16.3K | |
| Additional Paid In Capital | $159.5M | $0.00 | ||
| Depreciation And Amortization | $273.8K | $818.2K | ||
| Prepaid Expense Current | $27.6K | $43.6K | $343.6K | |
| Warrants And Rights Outstanding | $1.6M | $379.2K | ||
| Foreign Currency Transaction Gain Loss Unrealized | -$741.8K | $1.3M | ||
| Change In Fair Value Of Forward Purchase Agreement | -$308.1K | |||
| Formation And Operating Costs | $4.1M | $2.9M | ||
| Amortization Of Financing Costs | $287.3K | $2.0M | ||
| Lines Of Credit Current | $9.0M | |||
| Issuance Of Forward Purchase Agreement | -$308.1K | |||
| Interest Paid Net | $504.4K | $892.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$555.5K | $315.4K | -$420.5K | $220.4K | -$3.9M | $3.3M | $335.0K | -$2.0M | $2.0M | -$1.7M | -$3.0M | -$3.9M | -$3.3M | -$2.9M | -$960.0K | |||
| Investment Income Interest | $394.1K | $415.9K | $629.3K | $626.3K | $3.1M | $1.4M | $453.4K | $26.1K | $4.9K | $4.8K | $501.00 | |||||||
| Additional Paid In Capital | $214.9M | $209.7M | $201.7M | $200.7M | $210.7M | $7.1M | $5.8M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.6M | $4.7M | ||||
| Depreciation And Amortization | $216.4K | $144.6K | $60.1K | $67.7K | $68.5K | $68.9K | $75.3K | |||||||||||
| Prepaid Expense Current | $66.9K | $102.3K | $50.9K | $122.4K | $201.8K | $287.9K | $546.0K | $245.3K | $898.3K | |||||||||
| Warrants And Rights Outstanding | $3.3M | $735.9K | $420.5K | $841.0K | $1.3M | |||||||||||||
| Foreign Currency Transaction Gain Loss Unrealized | -$340.7K | -$358.5K | ||||||||||||||||
| Change In Fair Value Of Forward Purchase Agreement | -$633.2K | $325.1K | $0.00 | $0.00 | ||||||||||||||
| Formation And Operating Costs | $353.4K | $579.0K | $1.2M | $633.1K | $1.5M | $509.1K | $481.9K | $822.9K | $89.6K | |||||||||
| Amortization Of Financing Costs | ||||||||||||||||||
| Lines Of Credit Current | $14.0M | $14.0M | $14.0M | $12.7M | $12.7M | |||||||||||||
| Issuance Of Forward Purchase Agreement | $0.00 | -$308.1K | $0.00 | $0.00 | ||||||||||||||
| Interest Paid Net |
Most recent annual filing with the SEC: April 15, 2025
Data sourced from SEC EDGAR public filings as of August 8, 2026.